BONFRATE, LEONILDE
 Distribuzione geografica
Continente #
NA - Nord America 227
AS - Asia 207
EU - Europa 128
SA - Sud America 12
AF - Africa 1
OC - Oceania 1
Totale 576
Nazione #
US - Stati Uniti d'America 209
BD - Bangladesh 145
IT - Italia 122
CN - Cina 19
SG - Singapore 14
BR - Brasile 9
CA - Canada 9
VN - Vietnam 8
PK - Pakistan 7
HK - Hong Kong 6
IL - Israele 3
TT - Trinidad e Tobago 3
MX - Messico 2
SV - El Salvador 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BS - Bahamas 1
CL - Cile 1
EC - Ecuador 1
FR - Francia 1
GB - Regno Unito 1
IN - India 1
LT - Lituania 1
MA - Marocco 1
NI - Nicaragua 1
NL - Olanda 1
PH - Filippine 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 576
Città #
New York 91
Ashburn 20
Rome 15
Buffalo 12
Milan 9
Dallas 8
Santa Clara 8
Palermo 7
San Jose 7
Singapore 7
Bari 6
Beijing 6
Hong Kong 6
Islamabad 6
Los Angeles 6
Naples 6
Catania 4
Ho Chi Minh City 4
Treviglio 4
Cagliari 3
Charlotte 3
Netanya 3
Turin 3
Bologna 2
Brescia 2
Casamicciola Terme 2
Cascina 2
Columbus 2
Genoa 2
Mexico City 2
Modena 2
Montreal 2
Pescara 2
Pulsano 2
San Salvador 2
Shenzhen 2
Alliston 1
Amritsar 1
Amsterdam 1
Ancona 1
Arima 1
Atlanta 1
Augusta 1
Belo Horizonte 1
Boardman 1
Bracey 1
Bridgeport 1
Brooklyn 1
Bình Dương 1
California 1
Campinas 1
Campobasso 1
Castellammare di Stabia 1
Catanduva 1
Catanzaro 1
Chaguanas 1
Changsha 1
Chicago 1
Cincinnati 1
City of London 1
Colton 1
Crispano 1
Deltona 1
Denver 1
Elgin 1
Enfield 1
Florence 1
Fredericton 1
Gardner 1
General Rodríguez 1
Gioia Tauro 1
Grammichele 1
Grezzana 1
Hanoi 1
Harrison 1
Hyattsville 1
Hải Dương 1
Illapel 1
Iola 1
Jacksonville 1
Jeddah 1
Jonesboro 1
Kansas City 1
Karachi 1
Kenosha 1
Lenola 1
Little Rock 1
London 1
Long Beach 1
Lucca 1
Managua 1
Marrakesh 1
Massa 1
Miami 1
Monroe 1
Montecalvo Irpino 1
Montecchio Emilia 1
Nassau 1
Odesa 1
Orlando 1
Totale 334
Nome #
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation 46
Eradication rates in italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe 36
Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome 29
Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets 26
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm 21
Nitrogen dioxide pollution increases vulnerability to COVID-19 through altered immune function 20
Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis 18
The food-gut human axis: The effects of diet on gut microbiota and metabolome 16
Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad 16
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers 16
Mitochondria matter: Systemic aspects of nonalcoholic fatty liver disease (nafld) and diagnostic assessment of liver function by stable isotope dynamic breath tests 15
Different Variation of Intra-familial Body Mass Index subjected tCovid-19 Lockdown 15
A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy 15
Bovine pericardium patch wrapping intestinal anastomosis improves healing process and prevents leakage in a pig model 14
The Genetic Landscape of Diabetes Mellitus: Lessons from Monogenic and Polygenic Forms 13
Sourdough fermented breads are more digestible than those started with baker’s yeast alone: An in vivo challenge dissecting distinct gastrointestinal responses 12
Post COVID-19 irritable bowel syndrome 12
Genetic and clinical features of familial mediterranean fever (FMF) in a homogeneous cohort of patients from South-Eastern Italy 12
Neutrophil degranulation, endothelial and metabolic dysfunction in unvaccinated long COVID patients 11
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? 11
Autotaxin and Lysophosphatidic Acid Circulating Levels Correlate with Body Mass Index in Obese Subjects with MASLD 10
Use of GELSECTAN® in patients with irritable bowel syndrome (IBS): An Italian experience 10
Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability 9
Contribution of the microbiome for better phenotyping of people living with obesity 8
Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study 7
Irritable bowel syndrome and diet 7
Dynamic carbon 13 breath tests for the study of liver function and gastric emptying 7
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study 7
The inulin hydrogen breath test predicts the quality of colonic preparation 6
Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling 6
Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients 6
Breath tests with novel 13C-substrates for clinical studies of liver mitochondrial function in health and disease 6
Modifiable factors and genetic predisposition associated with gallbladder cancer. A concise review 6
The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017 5
Thyroid Function: A Target for Endocrine Disruptors, Air Pollution and Radiofrequencies 5
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 5
MicroRNA in colorectal cancer: New perspectives for diagnosis, prognosis and treatment 5
Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation 5
Nonalcoholic fatty liver disease (Nafld). mitochondria as players and targets of therapies? 5
Biochemical mechanisms in drug-induced liver injury: Certainties and doubts 5
Ramadan intermittent fasting reduces visceral fat and improves gastrointestinal motility 5
Effects of a Bioactive Vegetable-Enriched Diet on Autotaxin and Liver Fibrosis in MASLD with Evidence of Sex-Specific Responses: A Pilot Study 5
Gastrointestinal defects in gallstone and cholecystectomized patients 4
Novel therapeutics for the treatment of familial mediterranean fever: From colchicine to biologics 4
Faster detection of helicobacter pylori infection by 13c-urea breath test. Comparing short versus standard sampling time 4
Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography 4
Microbiota in health and irritable bowel syndrome: Current knowledge, perspectives and therapeutic options 4
Nonalcoholic fatty liver disease 4
Targets for current pharmacologic therapy in cholesterol gallstone disease 4
Noncommunicable diseases, climate change and iniquities: What COVID-19 has taught us about syndemic 4
Management of liver cirrhosis between primary care and specialists 4
Intestinal Barrier and Permeability in Health, Obesity and NAFLD 4
Assessing gastrointestinal symptoms and perception, quality of life, motility, and autonomic neuropathy in clinical studies 4
Prognostic role of serum albumin levels in patients with chronic heart failure 4
Altered distribution of caveolin-1 in early liver steatosis 4
Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery 4
The role of microbiota in nonalcoholic fatty liver disease 4
A novel therapeutic effect of statins on nephrogenic diabetes insipidus 3
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 3
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 3
The fatty liver as testimonial of systemic diseases. Further evidence from rheumatoid arthritis and confirmation for a leading role of internal medicine 3
Current views on genetics and epigenetics of cholesterol gallstone disease 3
Unexpected discovery of massive liver echinococcosis. A clinical, morphological, and functional diagnosis 3
Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test 3
Gut microbiota between environment and genetic background in familial mediterranean fever (Fmf) 3
Obesity and the risk and prognosis of gallstone disease and pancreatitis 3
Re-wiring the circuit: Mitochondria as a pharmacological target in liver disease 3
The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease 3
Bile acid physiology 3
AMA-positivity in AIH-patients with bile duct lesions running in between. Novel findings and perspectives 3
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 3
Concomitant, sequential, and hybrid therapy for H.pylori eradication: A pilot study 3
Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract 3
The pros and cons of biological effects of herbs and herb-derived compounds on liver tumorigenesis 3
Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin 3
Simvastatin increases AQP2 urinary excretion in hypercholesterolemic patients: A pleiotropic effect of interest for patients with impaired AQP2 trafficking 3
Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease 3
Self-reported symptoms after COVID-19 vaccination. Distinct sex, age, and geographical outcomes in Lebanese and Italian cohorts 3
Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver 3
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis 3
Corrigendum to ‘Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver.’ [European Journal of Internal Medicine 89C (2021) 56–64] (European Journal of Internal Medicine (2021) 89 (56–64), (S0953620521001084), (10.1016/j.ejim.2021.03.036)) 2
Management of chronic liver disease by general practitioners in Southern Italy: Unmet educational needs 2
Mitochondria in chronic liver disease 2
Effects of dietary education, followed by a tailored fructose-restricted diet in adults with fructose malabsorption 2
Effects of bifidobacterium longum and lactobacillus rhamnosuson gut microbiota in patients with lactose intolerance and persisting functional gastrointestinal symptoms: A randomised, double-blind, cross-over study 2
Gender-dependent impact of COVID-19 lockdown on metabolic and psychological aspects 2
Erratum: Novel therapeutics for the treatment of familial mediterranean fever: From colchicine to biologics (Clinical Pharmacology and Therapeutics (2013) DOI: 10.1038/clpt.2013.148) 2
Research update for articles published in EJCI in 2017 2
Liver steatosis, gut-liver axis, microbiome and environmental factors. A never-ending bidirectional cross-talk 2
Editorial to ‘A score for predicting invasive pulmonary aspergillosis in immunocompetent critically ill patients’ 2
Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations 2
Exploring liver mitochondrial function by13C-stable isotope breath tests: Implications in clinical biochemistry 2
The emerging problem of digital and self misuse of obesity management medications: Protecting their clinical value 2
Global multi-stakeholder endorsement of the MAFLD definition 1
Totale 670
Categoria #
all - tutte 6.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20253 0 0 0 0 0 0 0 0 0 0 0 3
2025/2026667 3 4 10 12 11 5 6 12 26 214 122 242
Totale 670